Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 5, 2018
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
[ Fri, Jan 05th 2018
] - WOPRAI
Thu, January 4, 2018
[ Thu, Jan 04th 2018
] - WOPRAI
[ Thu, Jan 04th 2018
] - WOPRAI
[ Thu, Jan 04th 2018
] - WOPRAI
Liav Abraham Upgraded (TEVA) to Strong Buy on, Jan 4th, 2018
Liav Abraham of Citigroup, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy on, Jan 4th, 2018.
Liav has made no other calls on TEVA in the last 4 months.
There are 9 other peers that have a rating on TEVA. Out of the 9 peers that are also analyzing TEVA, 5 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Vamil Divan of "Credit Suisse" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
- Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017
These are the ratings of the 4 analyists that currently disagree with Liav
- Ami Fadia of "Leerink Swann" Initiated at Sell and Held Target at $15 on, Tuesday, January 2nd, 2018
- Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
- Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
- Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017
